Status:
COMPLETED
Intracoronary Administration of Glucocorticoids as a Treatment Method for No-Glucocorticoid Treatment for No-Reflow in STEMI
Lead Sponsor:
Amosov National Institute of Cardiovascular Surgery
Conditions:
Ischemia-reperfusion Injury
No-reflow
Eligibility:
All Genders
40+ years
Phase:
PHASE2
Brief Summary
The goal of this clinical trial is to improve reperfusion therapy in STEMI patients with no-reflow phenomenon. Based on literature review and pathological studies, the investigators believe that myoca...
Detailed Description
The study involves comparing the main group receiving intracoronary methylprednisolone with a group of patients without intracoronary pharmacotherapy. Preliminary results: the use of methylprednisolon...
Eligibility Criteria
Inclusion
- TIMI 0/1 flow after successful artery obstruction stenting
- Men and women aged 40 years and older
Exclusion
- Coronary artery dissection
- Abrupt intraoperative coronary artery closure
- Intraoperative thrombosis
Key Trial Info
Start Date :
September 5 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06552442
Start Date
September 5 2020
End Date
June 1 2024
Last Update
August 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amosov National Institute of cardiovascular surgery
Kyiv, Amosov Street, 6, Ukraine, 03038